NCT06581354

Brief Summary

This study aims to evaluate the effect of provisionalization with a glass fiber composite framework on patient satisfaction and prosthetic complications before the insertion of a definitive PEKKTON framework when used under the screw-retained maxillary implant-supported prostheses at a one-year follow-up period.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
8

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2024

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 19, 2024

Completed
13 days until next milestone

Study Start

First participant enrolled

September 1, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 3, 2024

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2025

Completed
Last Updated

September 3, 2024

Status Verified

August 1, 2024

Enrollment Period

1 year

First QC Date

August 19, 2024

Last Update Submit

August 29, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • patient satisfaction

    During the 12-month follow-up period as follows (3 months after delivery, 6 months after delivery, and 12 months after delivery), Patient satisfaction for Implant-supported screw-retained full arch maxillary provisional prosthesis with early loading protocol utilizing 6 implants for constructing a resin glass fiber composite followed by (PEKKTON) framework will be registered and calculated by Questionnaire

    one year

Secondary Outcomes (1)

  • prosthetic complications

    one year

Study Arms (2)

no provisional prosthesis, pekkton is a definitive framework.

ACTIVE COMPARATOR

Implant-supported, full-arch maxillary prosthesis utilizing 6 implants, for constructing PEKKTON framework without provisionalization

Procedure: PROVISIONALIZATION

Glass fiber composite framework for provisionalization then pekkton framework.

EXPERIMENTAL

Implant-supported full arch maxillary provisional prosthesis protocol utilizing 6 implants for constructing a resin glass fiber composite framework followed by a definitive PEKKTON framework.

Procedure: PROVISIONALIZATION

Interventions

glass fiber composite as a temporary framework followed by PEKKTON definitive framework.

Glass fiber composite framework for provisionalization then pekkton framework.no provisional prosthesis, pekkton is a definitive framework.

Eligibility Criteria

Age40 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • a. Completely edentulous patients with Angle's Class I maxillomandibular relationship b. Age ranges from 40 to 65 years old. c. Adequate zone of keratinized attached mucosa (≥ 8mm) over the maxillary crest.
  • d. Absence of any medical disorder that could complicate the surgical phase or affect osseointegration.
  • e. The patient must have enough bone height for implants, a minimum length of bone f. 12 mm, and a minimum diameter of bone 6 mm. g. Patients with good oral hygiene. h. Complete denture wearer. i. Adequate interarch space for screw-retained prosthesis. j. Absence of any intra-oral pathological condition.

You may not qualify if:

  • \- a. Patients with recent extraction (less than three months). b. Patients with an inflamed ridge or candida infection c. Patients with the flabby ridge. d. Para functional habits. e. Cancer patients receiving chemotherapy and/or radiotherapy. f. Patients with uncontrolled diabetes, assessed by measuring glycosylated hemoglobin (HbA1c ≥ 7) g. Potentially uncooperative patients who are not willing to go through the proposed interventions.
  • h. Moderate-to-heavy daily smokers (more than ten per day)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Officials

  • rana shehata, phd

    faculty of dentistry Cairo university -Egypt

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The study will be based on different technical procedures for the fabrication of the frameworks. Since these differences are visible, the operator and the technician involved in the study as well as the outcome assessor cannot be blinded. But the statistician and patients will be blinded.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Group I: Intervention will be treated using a glass fiber composite as a temporary framework followed by PEKKTON definitive framework. Group II: Controls will be treated using PEKKTON definitive framework (no provisionalization).
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principal investigator (assistant lecturer of prosthodontics)

Study Record Dates

First Submitted

August 19, 2024

First Posted

September 3, 2024

Study Start

September 1, 2024

Primary Completion

September 1, 2025

Study Completion

November 1, 2025

Last Updated

September 3, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

sharing the main point of methodology and the final results